17 February 2023>: Clinical Research
EXOC3L1: A Novel Prognostic Biomarker Correlated with Immune Infiltration in Esophageal Squamous Cell CarcinomaZhan-Fei Zhang 12ABCDEFG*
Med Sci Monit 2023; 29:e938512
Figure 2 High expression of EXOC3L1 was associated with worse prognosis in patients with ESCC(A) Among the ESCC patients from TCGA, the expression of EXOC3L1 was significantly correlated with N stage. (B) High expression of EXOC3L1 was associated with higher pathological stage. (C) The ESCC patients with high EXOC3L1 expression had a shorter OS, DSS, and PFI.